Philipp Goertz

Suggest Changes
Learn More
Pathological cerebrospinal fluid (CSF) alterations like changes in amyloid-β1-42 and tau protein concentration are typical in Alzheimer's disease (AD). However, it remains unclear, if the composition(More)
Soluble amyloid β1–42 (Aβ1–42) peptide has recently been assigned a key role in early Alzheimer’s disease (AD) pathophysiology accounting for synaptic dysfunction before amyloid plaque formation and(More)